ERBB2 and breast cancer: Besides suppressing P13K/Akt pathway, quercetin can also downregulate human epidermal growth factor receptor 2 (Her-2/neu) in HER-2/neu overexpessing breast cancer cells which resulted in growth inhibition [77].